Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cibus, Inc. - Class A Common Stock (NQ: CBUS )

2.379 -0.101 (-4.07%)
Streaming Delayed Price Updated: 10:38 AM EST, Jan 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cibus, Inc. - Class A Common Stock

< Previous 1 2 3 Next >
Sidoti Events, LLC's Virtual January Micro-Cap Conference
Via ACCESS Newswire
Cibus, Inc. Announces $22.6 Million Registered Direct Offering Priced Above Nasdaq’s Minimum Price in Accordance with Nasdaq Rules
From Cibus US LLC
Via GlobeNewswire
Cibus’ Agriculture Breeding Breakthroughs Create New Industry Paradigms for Development and Commercialization of Plant Traits
From Cibus US LLC
Via GlobeNewswire
What Analysts Are Saying About Cibus Stock
Via Benzinga
Analyst Ratings For Cibus
Via Benzinga
Unveiling 5 Analyst Insights On Cibus
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Cibus, Albaugh LLC and RTDC Company Limited Affirm Collaboration to Enable Commercialization of Cibus’ First Gene Edited Weed Management Solution for U.S. Rice Growers
From Cibus US LLC
Via GlobeNewswire
Cibus and Biographica Announce Collaboration Using Artificial Intelligence (AI) to Advance Disease Resistance in Canola and Oilseed Rape
From Cibus US LLC; Biographica
Via GlobeNewswire
Cibus to Participate in the 13th Annual Roth Technology Conference
From Cibus US LLC
Via GlobeNewswire
Expert Ratings For Cibus
Via Benzinga
Why Cibus (CBUS) Stock Is Down 21% Wednesday
Cibus shares are trading lower by 23% Wednesday morning. The company announced a $12 million offering of 3 million shares priced at $4.00 each. 
Via Benzinga
Cibus Achieves Additional Milestone for Next Generation Gene Edits for Sclerotinia Resistance in Canola
From Cibus US LLC
Via GlobeNewswire
Cibus Reports Third Quarter Financial Results and Provides Year-to-Date Business Update for 2024
From Cibus US LLC
Via GlobeNewswire
Cibus Confirms its Herbicide Tolerance (HT2) Trait Shows Increased Tolerance to a Novel Herbicide for Weed Control in Canola
From Cibus US LLC
Via GlobeNewswire
Cibus to Report Third Quarter 2024 Financial Results on November 7, 2024 After the Market Close and Host Conference Call
From Cibus US LLC
Via GlobeNewswire
Cibus Inc. Announces Realigned Organization to Advance its Commercial Opportunities
Projected Cost Savings of Approximately $10 Million on Annualized Run-Rate Basis and Expected to Reduce Cash Use by Approximately 20% 
From Cibus US LLC
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Cibus Technology to be Featured on InnovAction Stage at the Euroseeds2024 Congress
From Cibus US LLC
Via GlobeNewswire
Cibus to Participate in the Food+ Forum during the 79th Session of the United Nations General Assembly
From Cibus US LLC
Via GlobeNewswire
Dow Jumps Over 100 Points; Fed Cuts Interest Rates By 0.5%
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Crude Oil Moves Lower; PowerFleet Shares Spike Higher
Via Benzinga
Exposures Fossil Fuels
US Stocks Mixed; General Mills Posts Upbeat Earnings
Via Benzinga
Cibus Announces Pricing of Public Offering of Class A Common Stock
From Cibus US LLC
Via GlobeNewswire
Cibus, Inc. Announces Proposed Public Offering of Class A Common Stock
From Cibus US LLC
Via GlobeNewswire
Cibus Completes First Field Trials in UK for Pod Shatter Reduction in Winter Oilseed Rape
From Cibus US LLC
Via GlobeNewswire
Cibus to Participate in Upcoming August Investor Events
From Cibus US LLC
Via GlobeNewswire
CBUS Stock Earnings: Cibus Misses EPS, Beats Revenue for Q2 2024
CBUS stock results show that Cibus missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Cibus Reports Second Quarter Financial Results and Provides First Half Business Update
From Cibus US LLC
Via GlobeNewswire
Cibus Achieves Positive Initial Field Trial Results for Stacked Gene Edited Herbicide Tolerant Traits in Rice
From Cibus US LLC
Via GlobeNewswire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.